Project AMPED
This is a multi-year, mixed methods study in Nevada and New Mexico is examining the patterns, reasons for, and health concerns related to methamphetamine use and opioid use.
If you do not find what you are looking for try searching with a different term or contact us.
This is a multi-year, mixed methods study in Nevada and New Mexico is examining the patterns, reasons for, and health concerns related to methamphetamine use and opioid use.
The Medicated Assisted Treatment recorded ECHO series focuses on supporting providers, staff, and administrators at facilities providing Medication-Assisted Treatment (MAT) services. By bringing together a team of MAT experts based at Northern Nevada HOPES and Center for Behavioral Health, the goal was to provide a platform for collaborative discussion and case review.
The MAT Resource Library is supported by the Los Angeles County Health Agency and Department of Public Health, Substance Abuse Prevention and Control. The site provides practical information on Medications for Addiction Treatment (MAT) for providers across health systems (e.g., physical health, mental health, and substance use disorder systems), as well as for patients.
Hosted by The Council of State Governments Justice Center, with Funding Support from the U.S. Department of Justice’s Bureau of Justice Assistance, this recorded webinar is designed for Justice and Mental Health Collaboration Program and Second Chance Act Reentry Program for Adults with Co-occurring Substance Use and Mental Disorders grantees and features speakers from three different grant programs that are utilizing MAT in jail and community-based settings for people involved in the justice system.
This toolkit provides correctional administrators and health care providers recommendations and tools for implementing medication-assisted treatment (MAT) in correctional settings. It provides examples from the field that can be widely applied and adapted for programs that serve justice-involved individuals.
Opioid Information Brochures for Providers or Consumers help educate on opioids and opioid use, including effects of opioid use, pregnancy and opioid use, medications for opioid use including opioid overdose reversal medications, and treatment options for persons using opioids.
In this presentation from Columbia Psychiatry, Dr. Steven Shoptaw, PhD focuses on the epidemiology, neurobiology, and treatment of stimulant use disorders.
This infographic shows different types of medications approved by the U.S. Food and Drug Administration for opioid overdose, withdrawal, and addiction.
This handbook provides guidance on using the web-based, multimedia tool Decisions in Recovery: Medications for Opioid Addiction. This handbook and the web-based tool offers information about medication-assisted treatment. Both resources help people living with opioid use disorder compare treatment options and discuss their preferences with a provider.
This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice -involved persons return to the community. It provides an overview of policies and evidence-based practices that reduce the risk of overdose and relapse.
SAMHSA offers a guide on MAT for opioid use disorder, which includes information on the various medications available for treatment, as well as resources for finding MAT providers and programs.
Individuals with opioid use disorder being released from prison are at particularly high risk for fatal overdose, yet virtually no U.S. correctional facilities initiate or continue medications for addiction treatment that would protect people against overdose following release from prison. This study explored whether a novel program in the state of Rhode Island that continued inmates’ opioid use disorder medications led to decreased drug overdoses.
This self-paced, online course offers an evidence based/informed review of buprenorphine vs methadone during pregnancy and recommendations for providers/organizations that treat pregnant, postpartum, and reproductive age patients.
The Division of Health Care Financing and Policy has taken action to address the opioid crisis by updating Nevada Medicaid policy and opening Medication-Assisted Treatment (MAT)-related evaluation and management (E/M) codes for billing by Nevada Medicaid providers effective with dates of service on or after January 1, 2020. In addition to MAT related E/M codes, Nevada Medicaid opened Screening, Brief Intervention, Referral to Treatment (SBIRT) codes to assist providers in performing screening services to recipients at risk or struggling with Substance Use Disorder (SUD).
This pocket guide is designed as a quick reference for information about medication-assisted treatment for opioid use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
P-COAT is an Alternative Payment Model designed by the American Medical Association (AMA) and The American Society of Addiction Medicine (ASAM). The P-COAT model was developed to expand access and utilization of medication assisted treatment (MAT) while also ensuring providers are appropriately reimbursed for the services they provide.
This toolkit is a resource for Peer Recovery Specialists (PRSs) to feel equipped to discuss MOUD with providers, people seeking recovery, and others with questions about this treatment option.